Previous close | 4.7390 |
Open | 4.7390 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 4.7390 - 4.7390 |
52-week range | 4.7390 - 4.7390 |
Volume | |
Avg. volume | 0 |
Market cap | 260.233M |
Beta (5Y monthly) | 0.81 |
PE ratio (TTM) | N/A |
EPS (TTM) | -44.7200 |
Earnings date | 05 Aug 2024 - 09 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
BOSTON, May 09, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.
BOSTON, May 08, 2024--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present information on the preclinical profile of STAR-0310 at the upcoming Society for Investigative Dermatology (SID) Annual Meeting in Dallas, Texas on May 16, 2024.